TEL AVIV, Israel, May 10, 2022/PRNewswire/ -- Lutris Pharma , a clinical stage biopharmaceutical company focused on?improving?anti-cancer?therapies?by?reducing dose?limiting?side?effects,?today?announced that Antoni Ribas, M.D., Ph.D., has been appointed as Chairman of the Board of Directors. Dr. Ribas, Founder of Lutris Pharma, has been a director of the company since its inception. "As founder of Lutris Pharma, there is nobody more closely connected to our vision...